Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 21:68:1605824.
doi: 10.3389/ijph.2023.1605824. eCollection 2023.

Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020

Affiliations

Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020

Yuanqi Mi et al. Int J Public Health. .

Abstract

Objectives: To determine factors associated with late and delayed antiretroviral therapy (ART) initiation in China and provide evidence for HIV prevention. Methods: Logistics regression model was used to determine factors associated with three outcomes: late (CD4 cell count <200 cells/µL or clinical AIDS diagnosis prior to ART initiation), delayed (more than 1 month between HIV diagnosis date and ART initiation) and either late or delayed ART initiation. Results: Multivariable analysis revealed that male, heterosexual, HIV diagnosis before 2014, HBV/HCV seropositive, and tuberculosis were associated with increased odds of all three outcomes. Conversely, married or cohabiting patients were less likely to have delayed ART initiation and either late or delayed ART initiation, while people who inject drugs were more likely to have these two outcomes. Additionally, older age was associated with an increased risk of having either late or delayed ART initiation, but a decreased risk of delayed ART initiation. Conclusion: The proportion of late and delayed ART initiation decreased significantly after the release of the 2016 guidelines in China. To further improve late diagnosis and early treatment, precise interventions for key populations are required.

Keywords: CD4; China; HIV; antiretroviral therapy; associated factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have any conflicts of interest.

Similar articles

Cited by

References

    1. UNAIDS. UNAIDS Data 2021 (2021). Available from: https://www.unaids.org/en/resources/documents/2021/2021_unaids_data. (Accessed June 1, 2022).
    1. Ndahimana J, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC, Kubwimana M, et al. Drug Resistance Mutations after the First 12 Months on Antiretroviral Therapy and Determinants of Virological Failure in Rwanda. Trop Med Int Health (2016) 21(7):928–35. 10.1111/tmi.12717 - DOI - PubMed
    1. Teasdale CA, Wang C, Francois U, Ndahimana J, Vincent M, Sahabo R, et al. Time to Initiation of Antiretroviral Therapy Among Patients Who Are ART Eligible in Rwanda: Improvement over Time. J Acquir Immune Defic Syndr (2015) 68(3):314–21. 10.1097/QAI.0000000000000432 - DOI - PMC - PubMed
    1. WHO Guidelines Approved by the Guidelines Review Committee. Guideline on when to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization (2015). - PubMed
    1. Xu J, Sönnerborg A, Gao L, Wang P, Bouey JZH, Cheng F. Delayed Treatment for People Living with HIV in China, 2004-2016: An Analysis of an Observational Cohort. Int J Environ Res Public Health (2020) 17(5):1809. 10.3390/ijerph17051809 - DOI - PMC - PubMed